BRUSSELS, July 24- U.S. cable group Liberty Global has offered to sell its pay TV channel Film1 in an attempt to win EU antitrust approval for its proposed acquisition of Dutch rival Ziggo, a person familiar with the matter said on Thursday.» Read More
LONDON, May 6- Representatives from U.S. drugmaker Pfizer and British pharmaceutical firm AstraZeneca will be called before a British parliamentary committee to discuss a potential takeover deal in the coming weeks, a committee spokesman said on Tuesday.
AstraZeneca acquired drug after buying Omthera in 2013. LONDON, May 6- AstraZeneca Plc has won U.S. approval for Epanova, a new pill for heart disease, providing a welcome- but relatively minor- piece of good news as it fights a $106 billion takeover approach from Pfizer Inc.
NEW YORK, May 5- Pfizer Inc's top officials said on Monday they are weighing all strategies, including potential hostile maneuvers, in the company's effort to seal a $106 billion takeover of British drugmaker AstraZeneca Plc.
Oncor avoided bankruptcy because of a credit provisions called a ring-fence put in place in 2007 to satisfy Texas legislators and regulators worried about the $40 billion debt created in the leveraged buyout by a group of private equity firms led by KKR& Co LP.
SYDNEY, May 5- Australian gas firm WestSide Corp Ltd on Monday rejected as undervalued a takeover offer from China's diversified energy company Landbridge Group Co Ltd that valued the company at A $177.6 million.
LONDON, May 4- Britain should conduct an independent assessment of a potential takeover of British pharmaceutical firm AstraZeneca by U.S. drugmaker Pfizer, opposition Labour party leader Ed Miliband said on Sunday. AstraZeneca rejected a 63 billion pound takeover bid from Pfizer on Friday, but the U.S. firm is expected to pursue its interest.
Employees at Pfizer Inc's U.S. research centers may want to dust off their resumes if the company's proposed acquisition of Britain's AstraZeneca comes to fruition.
May 3- Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal.
NEW YORK, May 3- Employees at Pfizer Inc's U.S. research centers, such as the La Jolla, California site that specializes in cancer drugs, may want to dust off their resumes if the company's proposed acquisition of Britain's AstraZeneca comes to fruition.
May 2- Private equity firm Arsenal Capital Partners is considering a sale of its business that helps U.S. oil and chemical companies reclaim import taxes, a partner at the firm said. Charter, which has annual net revenue of about $65 million to $70 million, is the largest U.S. petroleum and chemical drawback services provider.
LONDON, May 2- Britain's government said it was considering whether reassurances made by Pfizer over its potential takeover of AstraZeneca offered sufficient protection to maintain the country's life sciences sector and related jobs.
May 1- Pfizer Inc and AstraZeneca Plc have resumed talks about a trans-Atlantic merger of the two drug giants after Pfizer sweetened the terms of an earlier takeover offer for its British rival, the Wall Street Journal reported, citing people familiar with the matter.
VANCOUVER, May 1- Goldcorp Inc Chief Executive Chuck Jeannes said on Thursday he was disappointed the company failed in its takeover bid for Osisko Mining Corp but not overpaying for the smaller Canadian miner was the right thing to do.
*Biggest deal for Viacom since split from CBS. April 30- U.S.-based Viacom Inc said on Thursday it would buy British TV broadcaster Channel 5 from media baron Richard Desmond for $760 million as a keystone to develop its worldwide presence.
April 30- U.S.-based Viacom Inc said on Thursday it will buy British TV broadcaster Channel 5 from media baron Richard Desmond for $760 million as a keystone to develop its worldwide presence.
April 30- AT&T Inc has approached DirecTV about a possible acquisition of the satellite TV company, the Wall Street Journal reported, citing people familiar with the situation. A deal would likely be worth at least $40 billion, DirecTV's current market capitalization, the newspaper said.
U.S. drugmaker Pfizer Inc said on Monday it has made takeover bids for UK rival AstraZeneca Plc in a possible deal to merge the two into a UK holding company with a UK tax domicile. With the U.S. Congress deadlocked over tax-and-spending policy, the chances of an inversion crackdown becoming law soon were slim, said analysts, though it could not be ruled out.
*Planned $100 bln bid would be biggest ever of a UK firm. LONDON, April 30- British lawmakers intend to investigate U.S. drugmaker Pfizer's planned $100 billion takeover of British rival AstraZeneca in a bid to ensure scientific research and jobs are protected.
MUMBAI, April 30- An Indian court has temporarily halted generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of rival Ranbaxy Laboratories Ltd until it decides on a petition for a probe into alleged insider trading.
April 30- Exelon Corp, the largest U.S. nuclear power producer, said it would buy Pepco Holdings Inc for $6.83 billion to create the biggest electric and gas utility in the U.S. Exelon's $27.25 per share cash offer represents a near 20 percent premium to Pepco Holdings' Tuesday close of $22.79 on the New York Stock Exchange.